Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diagnostic Utility of Myeloperoxidase for Differentiating Irritable Bowel Syndrome From Inflammatory Bowel Disease in Patients With Lower GIT Symptoms

NCT07016529 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.

NCT NCT07016529
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07016529 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diagnostic Utility of Myeloperoxidase for Differentiating Irritable Bowel Syndrome From Inflammatory Bowel Disease in Patients With Lower GIT Symptoms
Lead sponsor
Sohag University
Phase
Observational
Overall status
Not yet recruiting
Start date
June 10, 2025
Completion date
December 20, 2025
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory bowel disease (ibd), irritable bowel syndrome (ibs)